Regulus Therapeutics
RGLS
#6949
Rank
$0.56 B
Marketcap
$8.16
Share price
0.00%
Change (1 day)
436.84%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of March 2025 : $65.36 Million USD

According to Regulus Therapeutics's latest financial reports the company has $65.36 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$75.77 M218.83%
2023-12-31$23.76 M-39.31%
2022-12-31$39.16 M-35.15%
2021-12-31$60.38 M94.24%
2020-12-31$31.08 M-8.89%
2019-12-31$34.12 M144.86%
2018-12-31$13.93 M-76.8%
2017-12-31$60.07 M-21.07%
2016-12-31$76.11 M-33.27%
2015-12-31$0.11 B-28.6%
2014-12-31$0.15 B40.12%
2013-12-31$0.11 B16.21%
2012-12-31$98.1 M157.18%
2011-12-31$38.14 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
GlaxoSmithKline
GSK
$4.44 B 6,699.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
$10.45 B 15,889.32%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$3.96 B 5,958.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$8.18 B 12,416.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
$2.72 B 4,068.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$29.61 M-54.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$16.50 B 25,144.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA